News und Analysen
Wonder Why Gilead Sciences Bought Kite Pharma? Here’s the Answer!
The next big thing in cancer treatment could be chimeric-antigen receptor T-cell therapy, or CAR-T, a novel approach that uncloaks cancer cells so that the immune system can destroy them. The....
Better Buy: Eli Lilly and Company vs. Pfizer Inc.
Two of the biggest pharmaceutical companies in the world have been around since the 19th century. Eli Lilly and Company (NYSE: LLY) was founded in 1876, while Pfizer Inc. (NYSE: PFE) began....
3 Stocks That Pay You
Other than the obvious reason that investors like the steady stream of income that comes from investing in dividend-paying stocks, the stability it conveys about a particular business provides a....
GlaxoSmithKline Is Wasting Money Paying a Dividend
As a general rule, I love companies that pay big dividends -- and British pharmaceutical giant GlaxoSmithKline (NYSE: GSK) pays some of the best dividends on the planet. That said, there's one....
3 Dividend Stocks That Thrive in Bear Markets
One of the benefits of dividend investing is the comfort that comes from the regular income stream. But market downturns can many times throw that sense of security out the window. What income....
Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences
On Monday, Gilead Sciences' (NASDAQ: GILD) wowed investors with an $11.9 billion deal to buy clinical-stage CAR-T drugmaker Kite Pharma (NASDAQ: KITE), and on Wednesday, the FDA approved Novartis'....
Why bluebird bio Inc Continued Its March Higher Again Today
Shares of bluebird bio (NASDAQ: BLUE) continued their seemingly unstoppable march higher this week, jumping another 10.8% today as of 2:58 p.m. EDT after two analysts increased their price targets....
Could Gilead Sciences Stock Skyrocket 25%? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Found: 3 Stocks Retirees Should Consider Adding
In the hunt for stocks to carry you through your retirement, you're probably looking for low-volatility stocks that supply reliable, steadily rising streams of income. You're past the time....
Why Analog Devices, Gilead Sciences, and Universal Display Jumped Today
The major benchmarks posted gains on Wednesday, as geopolitical fears and hurricane concerns gave way to positive economic news. A report released by the U.S. Department of Commerce showed that....
Why bluebird bio Inc Jumped Higher Today
bluebird bio (NASDAQ: BLUE) is up 10.1% at 3:40 p.m. EDT after Novartis (NYSE: NVS) got its chimeric antigen receptor T-cell (CAR-T) therapy Kymriah approved by the Food and Drug Administration....
Why Tiny Organovo Is Giving Money to Huge Biotech Amgen
In the first half of 2017, Amgen (NASDAQ: AMGN) paid out 140 times more in dividends to its shareholders than Organovo Holdings (NASDAQ: ONVO) made in revenue -- during its entire history as a....
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Once upon a time, Gilead Sciences (NASDAQ: GILD) was one of the hottest biotech stocks on the market. But for most of the last two years, Gilead was anything but hot, with its market cap losing....
Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today
Shares of Abeona Therapeutics (NASDAQ: ABEO) jumped 18.4% on Tuesday, while shares of Sangamo Therapeutics (NASDAQ: SGMO) ended up 11.3%. The former is clearly because Abeona received a....
Here's Why AVEO Pharmaceuticals Lost as Much as 19% Today
Shares of biopharma AVEO Pharmaceuticals (NASDAQ: AVEO) sank 19% Tuesday after investors had more time to digest Monday's news. That was, the company announced that the drug Fotivda gained....
3 Stocks to Buy for a Better Tomorrow
You can do well while you're doing good. Some companies set out to make the world a better place, and they also happen to have solidly profitable business models. Owning their stocks lets you....
This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier
If you're one of the millions of Americans diagnosed with diabetes, large pharmacy benefits manager (PBM) Express Scripts (NASDAQ: ESRX) has good news for you. There's something you can do that....
Why Juno Therapeutics Stock Is Blasting Off Today
Shares of Juno Therapeutics (NASDAQ: JUNO) are up by double digits for the second day in a row on extremely heavy volume. The catalyst behind this continued surge higher is the nearly $12 billion....
Why Catalent Inc. Rose as Much as 17% This Morning
Shares of drug-delivery technology specialist Catalent (NYSE: CTLT) jumped as much as 17% Tuesday morning in the wake of the company's 2017 fiscal year earnings report, released Monday after the....
Can Gilead Sciences Squeeze $12 Billion From Kite Pharma?
Gilead Sciences, Inc. (NASDAQ: GILD) just took a bold leap into the unknown with an agreement to acquire Kite Pharma Inc. (NASDAQ: KITE) for $180 per share or about $11.9 billion. Gilead's last....
These 3 Stocks Look Expensive but Are Actually Cheap
A stock's price -- or even its current valuation -- rarely tell the whole story regarding its ability to produce respectable returns on capital over the long-term. In fact, deep value can be....
3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%
There are fewer healthcare stocks with high yields than you might think. At least that's the case depending on your definition of "healthcare stocks" and "high yields." If you think a high-yield....
Here's What Else Gilead Sciences Gets by Buying Kite Pharma
Gilead Sciences' (NASDAQ: GILD) planned $11.9 billion acquisition of Kite Pharma (NASDAQ: KITE) nets it axi-cel, a CAR-T therapy that's already under FDA review. However, axi-cel isn't the only
Get Ready for More Acquisitions by Gilead Sciences
Investors woke up Monday morning to a pleasant surprise from Gilead Sciences (NASDAQ: GILD). The big biotech announced plans to acquire Kite Pharma (NASDAQ: KITE) for $11.9 billion. The market....
Why Thor Industries, IXYS Corporation, and Kite Pharma Jumped Today
Activity on the stock market was muted today as investors focused on the damage left by Hurricane Harvey. The major benchmarks showed mixed results, but stayed close to where they started the day.....